Category: fox-news/health/nutrition-and-fitness/weight-loss
New weight-loss pill hits the market, promising ‘greater flexibility’
FDA approves Foundayo, a once-daily weight loss pill by Lilly. Clinical trials showed adults lost an average of 27.3 pounds on the highest dose, although there are side effects.
Should you microdose Ozempic? Experts are split on risks vs benefits
Microdosing GLP-1 drugs is trending on social media and supported by some doctors, but experts warn the practice lacks a standard protocol and may undermine weight-loss results.
Rise of weight-loss pills could drive down the cost of airplane tickets
Analysts say GLP-1 weight-loss drugs could make airfare cheaper by reducing fuel costs as passengers get thinner. Experts discuss the theory.
Study reveals how rapidly weight comes back after quitting obesity medications
A new study reveals stopping GLP-1 weight loss drugs leads to rapid weight regain, nearly four times faster than quitting diet or exercise programs alone.
What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients
Clinical trials show retatrutide, Eli Lilly’s new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the improvement of other conditions in longer studies.
Weight-loss experts predict 5 major treatment changes likely to emerge in 2026
Weight-loss experts reveal their major predictions for 2026, from advanced GLP-1 treatments to AI-driven personalized therapy and minimally invasive procedures.
Denise Austin, 68, still fits into her iconic ’80s leotards and reveals her daily fitness habit
Legendary fitness instructor Denise Austin, 68, still fits into her leotards from the ’80s and ’90s. The longtime TV host shares her secrets for lasting weight loss.
Oprah joins wave of celebrities who revealed dramatic weight loss in 2025
Celebrities have embraced GLP-1 medications for dramatic weight loss in 2025. Oprah Winfrey, Amy Schumer, Meghan Trainor and Lizzo share their health journeys.
Older Americans are quitting GLP-1 weight-loss drugs for 4 key reasons
Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications like Ozempic and Wegovy despite results.
New Wegovy pill offers needle-free weight loss — but may not work for everyone
The FDA has approved the first Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight reduction as a needle-free alternative.
search
categories
Archives
navigation
Recent posts
- Republican Committee Raises Record Funds, But Voter Motivation Remains A Big Problem April 20, 2026
- The First Amendment Does Not Contain An Election-Year Exception April 20, 2026
- The Gray-Haired ‘Free DC’ Crowd Wants To Free The Capital From Law And Order April 20, 2026
- U.S., U.K. Lawmakers Finally Scrutinize China’s Use Of ‘Cultural Associations’ As Communist Fronts April 20, 2026
- How Feminism Created An Insufferable Class Of Supposedly ‘Infallible Females’ April 20, 2026
- The California Joy Killing Machine April 20, 2026
- Celebrities, global A”TIN flock to SB19″s ‘Wakas at Simula: The Trilogy Finale” April 20, 2026







